Vaccination with viable cells of an avirulent Salmonella typhimurium galE mutant provides mice with solid specific immunity against subsequent infection with a virulent smooth strain. Such a live vaccine is markedly more potent than one prepared from inactivated cells of the virulent smooth strain. The superiority of the live vaccine is particularly well demonstrated when the oral route of application is used. The protective capacity of the galE mutant is based on its ability to synthesize complete smooth-like cell wall lipopolysaccharide in vivo.
Vaccination with viable cells of an avirulent Salmonella typhimurium galE mutant provides mice with solid specific immunity against subsequent infection with a virulent smooth strain. Such a live vaccine is markedly more potent than one prepared from inactivated cells of the virulent smooth strain. The superiority of the live vaccine is particularly well demonstrated when the oral route of application is used. The protective capacity of the galE mutant is based on its ability to synthesize complete smooth-like cell wall lipopolysaccharide in vivo.
Live attenuated strains of Salmonella typhimurium yield more effective vaccines than heatkilled suspensions of virulent smooth strains, although both kinds of vaccine produce the same high titer of antibodies in the mouse (9, 10, 12) . There exist serious doubts also about whether acquired immunity can be passively transferred by the serum of resistant mice (4, 11, 13) . On the other hand, immunity can be passively transferred by macrophages (18) . It has been concluded that immunity in mouse typhoid is cellular in nature. with humoral antibodies playing only a minor role. This view is strongly supported by data showing that effective protection can also be conferred by live vaccine prepared from rough mutants lacking 0 antigens (14, 19) .
Our own investigations (7, 8) have shown that not all rough mutants are equally suitable as a live vaccine and that only galE mutants which are able to synthesize smooth-like lipopolysaccharide in vivo produce a degree of protection equal to that conferred by a sublethal infection with virulent smooth bacteria. This outstanding immunizing capacity is abolished by secondary mutations which prevent the biosynthesis of lipopolysaccharide with 0-specific side chains, and also under conditions where galactose is supplied exogenously (8) . These and other results (15, 17) neces- sary to compare once more a heat-inactivated vaccine with a number of live vaccines, the latter prepared from the epimeraseless mutant G30D and from a classical rough strain.
The major objection to most investigations which have used the mouse as an experimental model to study immunity to typhoid fever is that, with one exception (5), the challenge infection was always given parenterally. Host-parasite interaction in this case may therefore not parallel the natural infection. We accordingly carried out a number of experiments in which the animals were vaccinated and challenged orally. Since there is no general agreement with regard to the most suitable route for challenge, and since it has been suggested that live vaccines are only superior when the iv challenge route is used (3), we challenged the animals by both iv and ip routes. To assess the specificity of protection, one-half of the mice were challenged with S. typhlimurium C5S, and the other half received the antigenically different S. enteritidis strain 11. For the same reason, the challenge was given 2 and 6 weeks, respectively, after vaccination. The results are summarized in Fig. la and b .
MATERIALS AND METHODS

Bacteria
The best protection is unquestionably elicited by viable mutant G30D cells. Two weeks after vaccination, however, this protection is at least in part still nonspecific in nature. Thus, mice are protected against the heterologous S. enteritidis strain 11 just as well as against the homologous S. typhimurium strain C5S. This unusually long duration of nonspecific immunity can be explained by the fact that, when challenged, the mice are still harboring in their liver and spleen bacteria originally introduced by vaccination. Four weeks later, the situation has completely changed. The high degree of protection against the homologous strain remains unchanged, but the mice are no longer protected against infection with the heterologous strain and die as readily as the control animals. It is concluded that vaccination with viable cells of the epimeraseless mutant G30D provides mice with a long-lasting and specific immunity.
A certain amount of protection can also be given by a heat-inactivated vaccine, but at no time does it reach the same high level as that produced by viable cells. Mice vaccinated with inactivated smooth cells are quite well protected 2 weeks later against an ip challenge with the homologous S. typhimurium, but they are only weakly protected at this time when the challenge is given intravenously. After 6 weeks, protection against ip challenge seems to be reinforced. Thus, for the first 48 hr after challenge, the virulent bacteria are eliminated as effectively as in mice vaccinated with viable cells. Nevertheless, on the ensuing days, the surviving virulent bacteria multiply heavily, resulting in the death of some mice. At this time protection against iv challenge has markedly improved, but in this case also the number of challenge bacteria in liver and spleen rises during the first 12 days to about 108 organisms, representing approximately 10% of the lethal concentration. The same mice are at no time protected against a heterologous S. enteritidis infection. Protection induced by inactivated smooth cells thus appears to be very specific, though markedly less effective than that induced by viable mutant G30D cells.
A limited amount of resistance, lasting about 2 weeks, may also be induced by viable cells which do not possess any 0 antigens. This resistance against iv challenge is even higher than that induced by inactivated smooth cells. However, the same level of resistance can also be observed when mice are challenged with the heterologous strain. Moreover, 6 weeks after vaccination, the mice are no longer resistant and are protected no more than control animals. Vaccination with viable cells which do not possess O antigens therefore provides only nonspecific protection which is of short duration. It appears from these results that immunity to mouse typhoid is closely linked to 0 antigen structures. However, it remains obscure why inactivated smooth cells do not induce the same high resistance with viable cells of a proper attenuated strain. No information concerning this matter can be obtained from measurements of the agglutinin titer (Table 1 ). The titer is even higher in mice immunized with the dead vaccine than in those vaccinated with the attenuated strain. Vaccination and challenge by the oral route. Specific pathogen-free mice were vaccinated with 10"1 heat-inactivated cells of the smooth strain LT2, followed by a booster 7 days later with 109 viable cells of the same strain or with 1011 viable cells of the mutant G30D. The fate of the introduced organism was followed by making bacterial counts in both liver and spleen. Despite the higher dosage, G30D bacteria were eliminated Challenge i.v. Challenge was performed 6 weeks after vaccination, when all animals were free from the bacteria originally introduced at vaccination. To produce a lethal infection by the oral route, very high numbers of S. typhimurium cells must be given. The animals' resistance can be overcome by treating them orally with antibiotics or by using germfree animals (5). In our experiments, we challenged with a high dose. By giving 1011 virulent bacteria in 2 ml of saline orally, an infection can be induced which leads within 10 days to the death of 80% of the control animals. For comparative purposes, one-half of the mice were challenged intravenously with 500 LD,o of the same virulent C5S strain.
As seen in Fig. 2 , the superiority of the live 
DISCUSSION
In the present investigation, we confirmed the superiority of a live Salmonella vaccine against mouse typhoid over one prepared from heatinactivated cells. Vaccination with killed vaccine delays the spread of virulent bacteria in the liver and spleen but is unable to prevent subsequent multiplication of these bacteria in vivo to concentrations which lead to the death of at least some animals. In animals immunized with a live vaccine the multiplication of virulent challenge bacteria reaching the liver or spleen is effectively controlled, and they are finally eliminated. However, to be effective, live vaccine must be prepared from an attenuated smooth strain or, as in the case of the galE mutant G30D, from a rough strain capable of phenotypic reversion in vivo. Salmonella galE mutants, in which such a phenotyphic curing to the smooth type is prevented by secondary mutation, are not effective in a live vaccine. Vaccination with such a double mutant as LT2M1A provides mice with only a short-lasting, weak, nonspecific resistance. We are therefore faced with the paradox that salmonellae are only fully protective when they carry cell wall lipopolysaccharide structures which in themselves are significantly less effective.
The possibility that heat-labile antigens are responsible for the protective properties of viable cells was taken into account by inactivating the latter for 1 hr at 56 C. Under these mild conditions, the labile 0 antigen factor 5, which is considered to be particularly important in the induction of immunity to mouse typhoid, is not degraded (17) . It has been claimed repeatedly in the past that oral immunization with killed Salmonella also stimulates antibody production and induces significant protection of mice against infection with homologous organisms (16) . In the present investigation, the protection provided by orally administered live and dead vaccines was compared with that given by sublethal infection with a virulent Salmonella strain. The superiority of the live over the killed vaccines was even better demonstrated by using this procedure. Mice which received viable galE mutant G30D cells were almost as well protected against iv or oral challenge as those which survived infection with the virulent strain. On the other hand, the use of killed vaccine could at best inhibit the multiplication of virulent bacteria for a short time only. Finally, the challenge bacteria proliferated in the mice to the same extent as in control animals, where they also produced the same number of deaths.
